Dec 19 (Reuters) – The U.S. Food and Drug Administration has approved Cytokinetics’ drug to treat a rare heart condition, the company said on Friday.
(Reporting by Kamal Choudhury and Mariam Sunny in Bengaluru; Editing by Shinjini Ganguli)
Comments